$URG
UR-ENERGY INC Stock $urg

$urg Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000165495424013836 Filed on November 06, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$6.400M
YoY Change		11.27%
Cost Of Revenue		$5.613M
YoY Change		15.61%
Gross Profit		$787.0K
YoY Change		-12.26%
Gross Profit Margin		12.3%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$12.65M
YoY Change		-212.06%
Operating Profit		-$11.86M
YoY Change		14.16%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net		-$333.0K
YoY Change		-16750.0%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings		-$8.002M
YoY Change		-53.44%
Net Earnings / Revenue		-125.03%
Basic Earnings Per Share		-$0.02
Diluted Earnings Per Share		-$0.02
COMMON SHARES
Basic Shares Outstanding	364.1M shares	362.3M shares
Diluted Shares Outstanding		341.4M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents		$118.5M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory		$4.246M
Prepaid Expenses		$2.075M
Receivables
Other Receivables
Total Short-Term Assets		$125.0M
YoY Change		87.9%
LONG-TERM ASSETS
Property, Plant & Equipment		$25.50M
YoY Change		20.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets		$76.36M
YoY Change		18.3%
TOTAL ASSETS
Total Short-Term Assets		$125.0M
Total Long-Term Assets		$76.36M
Total Assets		$201.4M
YoY Change		53.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$5.729M
YoY Change		141.53%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$7.451M
YoY Change		-36.04%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$41.01M
YoY Change		-11.25%
TOTAL LIABILITIES
Total Short-Term Liabilities		$7.451M
Total Long-Term Liabilities		$41.01M
Total Liabilities		$48.46M
YoY Change		-16.24%
SHAREHOLDERS EQUITY
Retained Earnings		-$284.0M
YoY Change		15.73%
Common Stock		$412.6M
YoY Change		39.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$152.9M
YoY Change
Total Liabilities & Shareholders Equity		$201.4M
YoY Change		53.63%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$8.002M
YoY Change		-53.44%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	114849000	usd
CY2024Q3	us-gaap	Cash Cash	3611000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2366000	usd
CY2023Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	48185000	usd
CY2024Q3	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	118460000	usd
CY2023Q4	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	59700000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2571000	usd
CY2024Q3	us-gaap	Accelerated Share Repurchases Initial Price Paid Per Share AcceleratedShareRepurchasesInitialPricePaidPerShare	1.05
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59700000	usd
CY2024Q3	urg	Trade Receivables TradeReceivables	27000	usd
CY2023Q4	urg	Trade Receivables TradeReceivables	0	usd
CY2024Q3	urg	Current Portion Of Lease Receivable Net CurrentPortionOfLeaseReceivableNet	207000	usd
CY2023Q4	urg	Current Portion Of Lease Receivable Net CurrentPortionOfLeaseReceivableNet	77000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	4246000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2571000	usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2075000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1321000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	63669000	usd
CY2024Q3	us-gaap	Notes Receivable Net NotesReceivableNet	598000	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	208000	usd
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	10897000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	8549000	usd
CY2024Q3	us-gaap	Mineral Properties Net MineralPropertiesNet	39359000	usd
CY2023Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	34906000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	25502000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21044000	usd
CY2024Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	76356000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	64707000	usd
CY2024Q3	us-gaap	Assets Assets	201371000	usd
CY2023Q4	us-gaap	Assets Assets	128376000	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	7107000	usd
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	5694000	usd
CY2024Q3	urg	Warrants Liability Current WarrantsLiabilityCurrent	0	usd
CY2023Q4	urg	Warrants Liability Current WarrantsLiabilityCurrent	1743000	usd
CY2024Q3	urg	Current Portion Of Lease Liability CurrentPortionOfLeaseLiability	281000	usd
CY2023Q4	urg	Current Portion Of Lease Liability CurrentPortionOfLeaseLiability	162000	usd
CY2024Q3	us-gaap	Accrued Environmental Loss Contingencies Current AccruedEnvironmentalLossContingenciesCurrent	63000	usd
CY2023Q4	us-gaap	Accrued Environmental Loss Contingencies Current AccruedEnvironmentalLossContingenciesCurrent	69000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	7451000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10034000	usd
CY2024Q3	urg	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	3646000	usd
CY2023Q4	urg	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	11549000	usd
CY2024Q3	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	36412000	usd
CY2023Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	31236000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	948000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	687000	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	41006000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	43472000	usd
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	412606000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	302182000	usd
CY2024Q3	us-gaap	Surplus Notes SurplusNotes	20270000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4076000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3718000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-284038000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-250911000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	152914000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	74870000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	201371000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	128376000	usd
CY2024Q3	us-gaap	Revenues Revenues	6400000	usd
CY2023Q3	us-gaap	Revenues Revenues	5752000	usd
	us-gaap	Revenues Revenues	11053000	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	5613000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	4855000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	10079000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	14310000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	787000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	897000	usd
	us-gaap	Gross Profit GrossProfit	974000	usd
	us-gaap	Gross Profit GrossProfit	-2072000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	12650000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	11289000	usd
	us-gaap	Operating Expenses OperatingExpenses	40528000	usd
	us-gaap	Operating Expenses OperatingExpenses	20373000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-11863000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-10392000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-39554000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-22445000	usd
CY2024Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1220000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1079000	usd
CY2024Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	6000	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	13000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	22000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	335000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-333000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-33127000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17043000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25474000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	341418122	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	265279380	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	302077595	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	257385661	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	341418122	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	265279380	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	302077595	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	257385661	shares
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	40000	usd
CY2024Q1	urg	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	15849000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4227000	usd
CY2024Q1	urg	Stock Issued During Period Value Share Issue Costs StockIssuedDuringPeriodValueShareIssueCosts	-106000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	324000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-18258000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	254000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	22419000	usd
CY2024Q2	urg	Stock Issued During Period Value Share Issue Costs StockIssuedDuringPeriodValueShareIssueCosts	-700000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	325000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-6486000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	92758000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	298000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	37528000	usd
CY2023Q1	urg	Stock Issued During Period Value Share Issue Costs StockIssuedDuringPeriodValueShareIssueCosts	-2992000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	253000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	96556000	usd
CY2023Q2	urg	Stock Issued During Period Value Share Issue Costs StockIssuedDuringPeriodValueShareIssueCosts	-10000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	266000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-7401000	usd
	urg	Net Realizable Value Adjustments NetRealizableValueAdjustments	2061000	usd
	urg	Net Realizable Value Adjustments NetRealizableValueAdjustments	8158000	usd
	urg	Amortization Of Mineral Properties AmortizationOfMineralProperties	205000	usd
	urg	Amortization Of Mineral Properties AmortizationOfMineralProperties	828000	usd
	us-gaap	Depreciation Depreciation	1979000	usd
	us-gaap	Depreciation Depreciation	1546000	usd
	us-gaap	Accretion Expense AccretionExpense	518000	usd
	us-gaap	Accretion Expense AccretionExpense	371000	usd
	urg	Amortization Of Deferred Loan Costs AmortizationOfDeferredLoanCosts	33000	usd
	urg	Provision For Reclamation ProvisionForReclamation	0	usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	2000	usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	22000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	329000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	27000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-5600000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	520000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	0	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3736000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2956000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-623000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3011000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2105000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-32487000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16659000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5701000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1923000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5701000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1923000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	97568000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	46637000	usd
	urg	Share Issue Costs ShareIssueCosts	-4683000	usd
	urg	Share Issue Costs ShareIssueCosts	3002000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12228000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	969000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	5727000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	4027000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	40496000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-34000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	61108000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	21921000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	68249000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	129357000	usd
	us-gaap	Valuation Allowances And Reserves Period Increase Decrease ValuationAllowancesAndReservesPeriodIncreaseDecrease	2061000	usd
	us-gaap	Valuation Allowances And Reserves Period Increase Decrease ValuationAllowancesAndReservesPeriodIncreaseDecrease	8158000	usd
CY2024Q3	urg	Cash Pledged For Reclamation CashPledgedForReclamation	10885000	usd
CY2023Q4	urg	Cash Pledged For Reclamation CashPledgedForReclamation	8518000	usd
CY2024Q3	urg	Restricted Cash Other RestrictedCashOther	12000	usd
CY2023Q4	urg	Restricted Cash Other RestrictedCashOther	31000	usd
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	10897000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	8549000	usd
CY2023Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	34906000	usd
	urg	Change In Estimated Reclamation Costs ChangeInEstimatedReclamationCosts	4658000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	205000	usd
CY2024Q3	us-gaap	Mineral Properties Net MineralPropertiesNet	39359000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	24827000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	25502000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	43909000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	22865000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21044000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	5729000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1680000	usd
CY2024Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1068000	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	578000	usd
CY2024Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	310000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	108000	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	7107000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2366000	usd
CY2024Q3	us-gaap	Debt Current DebtCurrent	0	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	5727000	usd
CY2024Q3	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	0	usd
CY2023Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	33000	usd
CY2024Q3	us-gaap	Loans Payable Current LoansPayableCurrent	0	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	5694000	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	13292000	usd
	urg	Adjustments To Additional Paid In Capital Warrant Exercise AdjustmentsToAdditionalPaidInCapitalWarrantExercise	-4791000	usd
	urg	Effects For Foreign Exchange Rate Changes EffectsForForeignExchangeRateChanges	-413000	usd
CY2024Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3646000	usd
	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	4658000	usd
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	518000	usd
CY2024Q3	us-gaap	Asset Retirement Obligation AssetRetirementObligation	36412000	usd
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	363796235	shares
CY2023Q1	urg	Shares Issued Upon Public Offering SharesIssuedUponPublicOffering	34000000	shares
CY2023Q1	urg	Warrants To Purchase Shares WarrantsToPurchaseShares	17000000	shares
CY2023Q1	us-gaap	Accelerated Share Repurchases Initial Price Paid Per Share AcceleratedShareRepurchasesInitialPricePaidPerShare	1.18
CY2023Q1	urg	Class Of Warrant Or Right Exercise Price Of Warrants ClassOfWarrantOrRightExercisePriceOfWarrants	1.50
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	5100000	shares
CY2023Q1	us-gaap	Investment Sold Not Yet Purchased Balance Shares InvestmentSoldNotYetPurchasedBalanceShares	2550000	shares
CY2023Q1	urg	Proceeds From Warrant Exercises One ProceedsFromWarrantExercisesOne	46100000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	3000000.0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	43100000	usd
	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberBeginning	8900335	shares
	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceBeginning	0.87
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	500000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.79
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	2046760	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.58
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	353649	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.30
	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberEnding	6999926	shares
	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceEnding	0.98
	urg	Number Of Stock Options Exercised NumberOfStockOptionsExercised	1200000	usd
CY2024Q3	urg	In The Money Stock Options Outstanding InTheMoneyStockOptionsOutstanding	5262038	shares
CY2024Q3	urg	In The Money Stock Options Exercisable InTheMoneyStockOptionsExercisable	4496156	shares
	urg	Sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpected Forfeiture Rate SharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedForfeitureRate	0.050	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.671	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.038	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
	urg	Weighted Average Exercise Price WeightedAverageExercisePrice	2.46
	urg	Black Scholes Value Cad BlackScholesValueCad	1.33
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	641910	shares
	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueBeginning	1.33
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	6905	shares
	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted Weighted Average Grant Date Forfeited Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedWeightedAverageGrantDateForfeitedFairValue	1.51
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	595772	shares
	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueEnding	1.32
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	595772	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	708969000	usd
CY2023Q4	urg	Class Of Warrants Or Right Shares Issued On Exercise ClassOfWarrantsOrRightSharesIssuedOnExercise	27708750	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.46
	urg	Number Of Warrants Exercised NumberOfWarrantsExercised	-16376500	shares
	urg	Number Of Shares To Be Issued Upon Exercise Exercised NumberOfSharesToBeIssuedUponExerciseExercised	-8188250	shares
	urg	Per Share Exercise Price Exercised PerShareExercisePriceExercised	1.35
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	39041000	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.50
CY2024Q3	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue	6400	usd
CY2024Q3	urg	Revenues Percentage RevenuesPercentage	1.000	pure
CY2023Q3	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue	5752	usd
	urg	Revenues Percentage RevenuesPercentage	1.000	pure
	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue	11053	usd
	urg	Revenues Percentage RevenuesPercentage	1.000	pure
	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue	12238	usd
CY2023Q3	urg	Revenues Percentage RevenuesPercentage	1.000	pure
CY2023Q3	urg	Cost Of Product Sale CostOfProductSale	2523000	usd
	urg	Cost Of Product Sale CostOfProductSale	8018000	usd
	urg	Cost Of Product Sale CostOfProductSale	6152000	usd
CY2024Q3	urg	Lower Of Cost Or Nrv Adjustments LowerOfCostOrNRVAdjustments	722000	usd
CY2023Q3	urg	Lower Of Cost Or Nrv Adjustments LowerOfCostOrNRVAdjustments	2332000	usd
	urg	Lower Of Cost Or Nrv Adjustments LowerOfCostOrNRVAdjustments	2061000	usd
	urg	Lower Of Cost Or Nrv Adjustments LowerOfCostOrNRVAdjustments	8158000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4855000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10079000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14310000	usd
CY2024Q3	us-gaap	Exploration Expense ExplorationExpense	934000	usd
CY2023Q3	us-gaap	Exploration Expense ExplorationExpense	512000	usd
	us-gaap	Exploration Expense ExplorationExpense	2862000	usd
	us-gaap	Exploration Expense ExplorationExpense	1687000	usd
CY2024Q3	us-gaap	Development Costs DevelopmentCosts	10088000	usd
CY2023Q3	us-gaap	Development Costs DevelopmentCosts	9339000	usd
	us-gaap	Development Costs DevelopmentCosts	31730000	usd
	us-gaap	Development Costs DevelopmentCosts	13577000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1397000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1314000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5418000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4738000	usd
CY2024Q3	urg	Accretion Expenses AccretionExpenses	231000	usd
CY2023Q3	urg	Accretion Expenses AccretionExpenses	124000	usd
	urg	Accretion Expenses AccretionExpenses	518000	usd
	urg	Accretion Expenses AccretionExpenses	371000	usd
CY2023Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	11289000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	40528000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	20373000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	118460000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54627000	usd
CY2024Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	10897000	usd
CY2023Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	8434000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	129357000	usd
	urg	Debt Instrument Interest Expense DebtInstrumentInterestExpense	100000	usd
CY2023Q3	urg	Debt Instrument Interest Expense DebtInstrumentInterestExpense	100000	usd
	urg	Debt Instrument Interest Expense DebtInstrumentInterestExpense	400000	usd
CY2024Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	600000	usd
CY2024Q3	urg	Currency Risk CurrencyRisk	2500000	cad
CY2024Q3	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	7100000	usd
CY2024Q3	urg	Lease Liability Current LeaseLiabilityCurrent	300000	usd
CY2024Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	118500000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001375205
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	641910	shares
CY2024Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	39041000	shares
CY2024Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.50
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	270898900	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	363796235	shares
CY2024Q3	urg	Debt Instrument Interest Expense DebtInstrumentInterestExpense	0	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-33905
	dei	Entity Registrant Name EntityRegistrantName	UR-ENERGY INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	Z4
	dei	Entity Address Address Line1 EntityAddressAddressLine1	10758 West Centennial Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
	dei	Entity Address City Or Town EntityAddressCityOrTown	Littleton
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80127
	dei	City Area Code CityAreaCode	720
	dei	Local Phone Number LocalPhoneNumber	981-4588
	dei	Security12b Title Security12bTitle	Common stock
	dei	Trading Symbol TradingSymbol	URG
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	364101038	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	118460000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	125015000	usd
CY2023Q4	us-gaap	Surplus Notes SurplusNotes	19881000	usd
	us-gaap	Revenues Revenues	12238000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	406000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2288000	usd
CY2024Q3	urg	Warrant Liability Revaluation Gainloss WarrantLiabilityRevaluationGainloss	2968000	usd
CY2023Q3	urg	Warrant Liability Revaluation Gainloss WarrantLiabilityRevaluationGainloss	-7216000	usd
	urg	Warrant Liability Revaluation Gainloss WarrantLiabilityRevaluationGainloss	4442000	usd
	urg	Warrant Liability Revaluation Gainloss WarrantLiabilityRevaluationGainloss	-4155000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-325000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-8002000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-17187000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-25184000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-23000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	144000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	358000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-290000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8025000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-32769000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	74870000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	76946000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	876000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	70922000	usd
CY2024Q3	urg	Stock Issued During Period Value Share Issue Costs StockIssuedDuringPeriodValueShareIssueCosts	-3877000	usd
CY2024Q3	urg	Redemption Of Rsus RedemptionOfRsus	-56000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	316000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-8025000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	152914000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	62499000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-1030000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	89411000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	672000	usd
CY2023Q3	urg	Redemption Of Rsus Amount RedemptionOfRsusAmount	-81000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	260000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-17043000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	73219000	usd
	us-gaap	Profit Loss ProfitLoss	33127000	usd
	us-gaap	Profit Loss ProfitLoss	25184000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	965000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	779000	usd
	urg	Amortization Of Deferred Loan Costs AmortizationOfDeferredLoanCosts	33000	usd
	urg	Provision For Reclamation ProvisionForReclamation	6000	usd
	urg	Warrant Liability Revaluation Loss Gain WarrantLiabilityRevaluationLossGain	4442000	usd
	urg	Warrant Liability Revaluation Loss Gain WarrantLiabilityRevaluationLossGain	-4155000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	565000	usd
	urg	Rsus Redeemed For Cash RsusRedeemedForCash	-56000	usd
	urg	Rsus Redeemed For Cash RsusRedeemedForCash	-81000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	99330000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41140000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	63061000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>1. Nature of Operations</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">Ur-Energy Inc. (the “Company”) was incorporated on March 22, 2004, under the laws of the Province of Ontario. The Company continued under the Canada Business Corporations Act on August 8, 2006. The Company is an exploration stage issuer, as defined by United States Securities and Exchange Commission (“SEC”). The Company is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located primarily in Wyoming. The Company commenced uranium production at its Lost Creek Project in Wyoming in 2013.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">Due to the nature of the uranium recovery methods used by the Company on the Lost Creek Property, and the definition of “mineral reserves” under Subpart 1300 to Regulation S-K (“S-K 1300”), the Company has not determined whether the property contains mineral reserves. The recoverability of amounts recorded for mineral properties is dependent upon the discovery of economic resources, the ability of the Company to obtain the necessary financing to develop the properties and upon attaining future profitable production from the properties or sufficient proceeds from the disposition of the properties.</p>
CY2023Q4	us-gaap	Cash Cash	11515000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	4246000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	50329000	usd
CY2024Q1	us-gaap	Payments For Loans PaymentsForLoans	4400000	usd
	urg	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	4442000	usd
CY2023Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	31236000	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	270898900	shares
CY2023Q1	urg	Common Shares Purchase CommonSharesPurchase	19550000	shares
CY2024Q3	urg	Shares Issued Upon Public Offering SharesIssuedUponPublicOffering	57150000	shares
CY2024Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	8572500	shares
CY2024Q3	us-gaap	Shares Issued SharesIssued	65722500	shares
CY2024Q3	urg	Proceeds From Warrant Exercises One ProceedsFromWarrantExercisesOne	69000000.0	usd
CY2024Q3	us-gaap	Costs And Expenses CostsAndExpenses	3800000	usd
CY2024Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	65200000	usd
CY2024Q3	urg	Closing Stock Price Per Share ClosingStockPricePerShare	1.19
	urg	Expected Life Years ExpectedLifeYears	P4Y
	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedInPeriod	-39233	shares
	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted Weighted Average Grant Date Released Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedWeightedAverageGrantDateReleasedFairValue	1.30
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P0Y8M12D
CY2023Q1	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	39100000	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	55417500	shares
CY2024Q3	urg	Class Of Warrants Or Right Shares Issued On Exercise ClassOfWarrantsOrRightSharesIssuedOnExercise	19520500	shares
CY2024Q3	urg	Cost Of Product Sale CostOfProductSale	4891000	usd
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5613000	usd
CY2024Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	12650000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	63061000	usd
	us-gaap	Supplementary Insurance Information Benefits Claims Losses And Settlement Expense SupplementaryInsuranceInformationBenefitsClaimsLossesAndSettlementExpense	1400000	usd
CY2024Q3	us-gaap	Purchase Obligation PurchaseObligation	600000	usd
CY2023Q4	us-gaap	Purchase Obligation PurchaseObligation	200000	usd

Files In Submission

Name	View Source	Status
0001654954-24-013836-index-headers.html	Edgar Link	pending
0001654954-24-013836-index.html	Edgar Link	pending
0001654954-24-013836.txt	Edgar Link	pending
0001654954-24-013836-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
urg-20240930.xsd	Edgar Link	pending
urg_10q.htm	Edgar Link	pending
urg_ex311.htm	Edgar Link	pending
urg_ex312.htm	Edgar Link	pending
urg_ex321.htm	Edgar Link	pending
urg_ex322.htm	Edgar Link	pending
urg-20240930_cal.xml	Edgar Link	unprocessable
urg-20240930_pre.xml	Edgar Link	unprocessable
urg-20240930_lab.xml	Edgar Link	unprocessable
urg-20240930_def.xml	Edgar Link	unprocessable
urg_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$URG
UR-ENERGY INC Stock $urg

2024 Q4 Form 10-Q Financial Statement

#000165495424013836 Filed on November 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$URG UR-ENERGY INC Stock $urg

2024 Q4 Form 10-Q Financial Statement

#000165495424013836 Filed on November 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$URG
UR-ENERGY INC Stock $urg